In line with the mouse data, HCC patients with the W4P variant had significantly higher serum IL-6 levels than those carrying WT LHB (Figure 3D), while there was no significant difference in the level of TNF-α (Figure 3E). Here, IL6 is linked to hepatocellular carcinoma.